Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yarrow and Moringa Nanoparticles for Gingivitis
NCT06070571Phase 1Completed
- Sponsor
- Deraya University
- Start
- May 2022
- Primary completion
- Dec 2022
- Modality
- HM (Herbal Medicine)
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of yarrow + moringa in gingivitis (2 arms), sponsored by Deraya University. Primary endpoints: Antibacterial activity at 2 weeks and Anti-inflammatory activity at 2 weeks. Started May 2022; status: completed.
02
Drugs
yarrow + moringa
03
Conditions
gingivitis
Beyond the preview
Go deeper on NCT06070571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06070571.